All Updates

All Updates

icon
Filter
Partnerships
Inocras and IMBdx partner to enhance cancer care through advanced diagnostic techniques
Precision Medicine
May 22, 2024
This week:
Funding
Lhyfe receives EUR 11 million grant from Klimatklivet for green hydrogen project in Sweden
Hydrogen Economy
Yesterday
Product updates
XRAI Glass launches AR One glasses at USD 1449 for hearing-impaired individuals
Extended Reality
Yesterday
Funding
VR therapy platform CUREosity raises EUR 3.8 million in funding to expand market presence
Extended Reality
Yesterday
Last week:
Product updates
Coinbase updates mobile wallet to add decentralized app browser
Decentralized Finance (DeFi)
Jun 22, 2024
Product updates
Coinbase updates mobile wallet to add decentralized app browser
Web3 Ecosystem
Jun 22, 2024
M&A
OpenAI acquires Rockset to power retrieval infrastructure
Data Infrastructure & Analytics
Jun 21, 2024
M&A
OpenAI acquires Rockset to power retrieval infrastructure
Foundation Models
Jun 21, 2024
Partnerships
Product updates
Anthropic releases Claude 3.5 Sonnet, the first model in the 3.5 series
Foundation Models
Jun 21, 2024
Funding
Paramount Planet Product raises USD 1 million in federal grant funding to support commercialization
Bio-based Materials
Jun 21, 2024
Regulation/policy
Apple delays launch of Apple Intelligence features in EU citing regulatory concerns
Generative AI Applications
Jun 21, 2024
Precision Medicine

Precision Medicine

May 22, 2024

Inocras and IMBdx partner to enhance cancer care through advanced diagnostic techniques

Partnerships

  • IMBdx has partnered with Inocras to improve cancer patient care in the US by enhancing genomic analysis used in cancer profiling and providing broader diagnostic options.

  • The partnership will focus on expanding IMBdx’s liquid-biopsy-based cancer diagnostics in the US through Inocras. This collaboration aims to present a fresh approach to patient care by pairing whole genome data with liquid biopsy. It provides an alternative to traditional tissue biopsy when not feasible. The goal is to create a seamless and effective pathway for cancer care through these advanced diagnostic services.

  • Inocras, formerly Genome Insight, is a biotechnology company that provides whole genome sequencing (WGS) and bioinformatics solutions. Inocras provides personalized diagnostic solutions focusing on genetically driven diseases such as cancer and rare diseases. The company's key products are CancerVision and RareVision, WGS-based tests designed to offer a detailed analysis of a patient's genetic makeup to support treatment planning and clinical trial matching.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.